These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 15298843

  • 1. Clinical inquiries. Is methylphenidate useful for treating adolescents with ADHD?
    Mott TF, Leach L, Johnson L.
    J Fam Pract; 2004 Aug; 53(8):659-61. PubMed ID: 15298843
    [No Abstract] [Full Text] [Related]

  • 2. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
    Oberpichler-Schwenk H.
    Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
    [No Abstract] [Full Text] [Related]

  • 3. Focalin XR for ADHD.
    Med Lett Drugs Ther; 2009 Mar 23; 51(1308):22-4. PubMed ID: 19305368
    [No Abstract] [Full Text] [Related]

  • 4. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P, Sever J, Weizman A.
    Harefuah; 2011 Oct 23; 150(10):788-90, 814. PubMed ID: 22111124
    [Abstract] [Full Text] [Related]

  • 5. Clinical and cognitive response to extended-release methylphenidate (Medikinet) in attention deficit/hyperactivity disorder: efficacy evaluation.
    Fernández-Jaén A, Fernández-Mayoralas DM, Pardos A, Calleja-Pérez B, Muñoz Jareño N.
    Adv Ther; 2009 Dec 23; 26(12):1097-110. PubMed ID: 20082241
    [Abstract] [Full Text] [Related]

  • 6. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ, Merkel RL, Moore M, Thorndike F, Muller C, Kovatchev B.
    Pediatrics; 2006 Sep 23; 118(3):e704-10. PubMed ID: 16950962
    [Abstract] [Full Text] [Related]

  • 7. [Methylphenidate of retard forms in children and adolescents with ADHD - an overview].
    Pelz R, Banaschewski T, Becker K.
    Klin Padiatr; 2008 Sep 23; 220(2):93-100. PubMed ID: 18157763
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T.
    J Clin Psychopharmacol; 2009 Jun 23; 29(3):239-47. PubMed ID: 19440077
    [Abstract] [Full Text] [Related]

  • 9. Clinical inquiries. Does increasing methylphenidate dose aid symptom control in ADHD?
    Ibay AD, Bascelli LM, Graves RS, Hill J.
    J Fam Pract; 2003 May 23; 52(5):400, 403. PubMed ID: 12737774
    [No Abstract] [Full Text] [Related]

  • 10. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ, Chou MC, Tzang RF, Hsu YC, Gau SS, Chen SJ, Wu YY, Huang YF, Liang HY, Cheng H.
    Psychiatry Clin Neurosci; 2009 Apr 23; 63(2):167-75. PubMed ID: 19335386
    [Abstract] [Full Text] [Related]

  • 11. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.
    Wilens TE, McBurnett K, Bukstein O, McGough J, Greenhill L, Lerner M, Stein MA, Conners CK, Duby J, Newcorn J, Bailey CE, Kratochvil CJ, Coury D, Casat C, Denisco MJ, Halstead P, Bloom L, Zimmerman BA, Gu J, Cooper KM, Lynch JM.
    Arch Pediatr Adolesc Med; 2006 Jan 23; 160(1):82-90. PubMed ID: 16389216
    [Abstract] [Full Text] [Related]

  • 12. Safe and effective methylphenidate therapy in a pediatric patient with glaucoma.
    Lewis H, Lewis J.
    Atten Defic Hyperact Disord; 2012 Mar 23; 4(1):37-9. PubMed ID: 22311620
    [Abstract] [Full Text] [Related]

  • 13. [Medical treatments of hyperactive child: about the new pharmaceutical forms of methylphenidate marketed in France].
    Le Heuzey MF, Vergnaud S, Mouren MC.
    Arch Pediatr; 2006 Jan 23; 13(1):100-3. PubMed ID: 16239100
    [Abstract] [Full Text] [Related]

  • 14. Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments.
    Prince JB.
    Child Adolesc Psychiatr Clin N Am; 2006 Jan 23; 15(1):13-50. PubMed ID: 16321724
    [Abstract] [Full Text] [Related]

  • 15. Transdermal methylphenidate (Daytrana) for ADHD.
    Med Lett Drugs Ther; 2006 Jun 19; 48(1237):49-51. PubMed ID: 16785850
    [No Abstract] [Full Text] [Related]

  • 16. [A reply concerning scientologists and ADHD: Scientific evidence and indications for treatment with methylphenidate].
    Zetterström R.
    Lakartidningen; 2002 Mar 19; 99(14):1618-9. PubMed ID: 12025221
    [No Abstract] [Full Text] [Related]

  • 17. Clinical review: evidence-based diagnosis and treatment of ADHD in children.
    Nair J, Ehimare U, Beitman BD, Nair SS, Lavin A.
    Mo Med; 2006 Mar 19; 103(6):617-21. PubMed ID: 17256270
    [Abstract] [Full Text] [Related]

  • 18. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
    Polanczyk G, Zeni C, Genro JP, Guimarães AP, Roman T, Hutz MH, Rohde LA.
    Arch Gen Psychiatry; 2007 Feb 19; 64(2):218-24. PubMed ID: 17283289
    [Abstract] [Full Text] [Related]

  • 19. Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial.
    Golubchik P, Sever J, Zalsman G, Weizman A.
    Int Clin Psychopharmacol; 2008 Jul 19; 23(4):228-31. PubMed ID: 18446088
    [Abstract] [Full Text] [Related]

  • 20. Optimizing ADHD therapy with sustained-release methylphenidate.
    Lawrence JD, Lawrence DB, Carson DS.
    Am Fam Physician; 1997 Apr 19; 55(5):1705-9, 1711-2. PubMed ID: 9105199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.